CISplatin (WG Critical Care, LLC)


Welcome to the PulseAid listing for the CISplatin drug offered from WG Critical Care, LLC. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: WG Critical Care, LLC
NON-PROPRIETARY NAME: CISplatin
SUBSTANCE NAME: CISPLATIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-01-13
END MARKETING DATE: 0000-00-00


CISplatin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCISplatin from WG Critical Care, LLC
LABELER NAME: WG Critical Care, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2012-01-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 44567-509_2308221c-f942-4c1e-a9f9-2ba58c43d362
PRODUCT NDC: 44567-509
APPLICATION NUMBER: NDA018057

Other CISPLATIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare, Inc.Cisplatin
Alvogen Inc.Cisplatin
Athenex Pharmaceutical Division, LLC.Cisplatin
BluePoint LaboratoriesCisplatin
Corden Pharma Latina S.p.A.Platinol
Fresenius Kabi USA, LLCCisplatin
Gland Pharma LimitedCISPLATIN
Mylan Institutional LLCCisplatin
Pfizer Laboratories Div Pfizer Inc.Cisplatin
Teva Parenteral Medicines, Inc.Cisplatin
WG Critical Care, LLCCISplatin